D. Azoulay

发表

The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantations

S. Fan, H. Kluin-Nelemans, R. Porte, 2012, Journal of thrombosis and haemostasis : JTH.

Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism

D. Azoulay, S. Giryes, R. Nasser, 2019, Journal of clinical neurology.

Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS

M. Schwartz, Arseny Finkelstein, M. Koronyo-Hamaoui, 2011, PloS one.

Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis

M. Schwartz, N. Amariglio, G. Rechavi, 2009, Journal of cellular and molecular medicine.

Bortezomib‐induced peripheral neuropathy is related to altered levels of brain‐derived neurotrophic factor in the peripheral blood of patients with multiple myeloma

D. Lavie, D. Ben‐Yehuda, M. Gatt, 2014, British journal of haematology.

Low brain-derived neurotrophic factor protein levels and single-nucleotide polymorphism Val66Met are associated with peripheral neuropathy in type II diabetic patients

D. Azoulay, E. Kaykov, A. Bashkin, 2020, Acta Diabetologica.

Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation.

Y. Herishanu, A. Braester, D. Azoulay, 2018, Experimental hematology.

Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate

A. Karni, D. Azoulay, B. Shihman, 2005, Journal of Neuroimmunology.

Flow cytometry detection of reactive plasmacytosis and HRS-like cells as a challenging initial finding in angioimmunoblastic T cell lymphoma

V. Sonkin, A. Braester, D. Azoulay, 2016, Journal of Hematopathology.

Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery

N. Assy, D. Azoulay, H. Rechnitzer, 2021, International journal of molecular sciences.

Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine‐induced peripheral neuropathy in patients with lymphoma

D. Azoulay, L. Akria, R. Nasser, 2018, British journal of haematology.

Association between Met-BDNF allele and vulnerability to paclitaxel-induced peripheral neuropathy

B. Gross, A. Braester, D. Azoulay, 2015, Breast Cancer Research and Treatment.

Hairy cell leukemia‐variant without typical morphology and with near‐tetraploid DNA content

L. Trakhtenbrot, V. Sonkin, Eugene Dementiev, 2018, Cytometry. Part B, Clinical cytometry.

Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9

M. Schwartz, D. Farkas, K. Black, 2009, Journal of neurochemistry.

Loss of CD55 in Eculizumab-Responsive Protein-Losing Enteropathy.

D. Geiger, H. Mandel, D. Magen, 2017, The New England journal of medicine.

Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficial.

D. Azoulay, N. Horowitz, 2021, Blood reviews.

Interferon-β therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism

F. Fahoum, A. Karni, Karin Mausner-Fainberg, 2009, Journal of Neuroimmunology.

BDNF Val66Met is Associated with Pre-existing but not with Paclitaxel-induced Peripheral Neuropathy in an Israeli Cohort of Breast Cancer Patients.

D. Azoulay, R. Sharon, A. Leibovici, 2018, The Israel Medical Association journal : IMAJ.

Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10+ diffuse large B‐cell lymphoma and follicular lymphoma

Eugene Dementiev, D. Azoulay, L. Akria, 2019, Cytometry. Part B, Clinical cytometry.

Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection

A. Karni, D. Azoulay, Natali Urshansky, 2008, Journal of Neuroimmunology.

Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher Disease

S. Revel-Vilk, A. Zimran, D. Azoulay, 2022, International journal of molecular sciences.

P1633: LOW SERUM BDNF LEVELS ARE ASSOCIATED WITH LOWER PLATELETS’ CD62P REACTIVITY AND INCREASED BLEEDING TENDENCY IN PATIENTS WITH GAUCHER DISEASE

S. Revel-Vilk, A. Zimran, D. Azoulay, 2022, HemaSphere.

Laboratory Indices in Patients with Positive and Borderline Flow-cytometry EMA-screening Test Results for Hereditary Spherocytosis.

D. Azoulay, A. Kuperman, E. Shaoul, 2022, The Journal of pediatrics.

Immune-based therapy for Alzheimer's disease is associated with elevated levels of IL-10 in the brain

M. Schwartz, D. Farkas, K. Black, 2009, Alzheimer's & Dementia.

Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients

A. Braester, D. Azoulay, M. Barhoum, 2016, International journal of laboratory hematology.

Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration

D. Azoulay, N. Horowitz, E. Shaoul, 2020, Journal of Infection.

Brain‐derived neurotrophic factor as a potential biomarker of chemotherapy‐induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization

D. Azoulay, N. Horowitz, 2020, British journal of haematology.

Alterations in Platelet Levels of Brain-Derived Neurotrophic Factor Are Associated with Clinical Response to Bortezomib in Patients with Multiple Myeloma

A. Braester, D. Azoulay, C. Suriu, 2014 .

Koronyo-Hamaoui, M. et al. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J. Neurochem. 111, 1409-1424

M. Schwartz, D. Farkas, K. Black, 2009 .

Interferon-β therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism

F. Fahoum, A. Karni, Karin Mausner-Fainberg, 2009, Journal of Neuroimmunology.

Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation.

Y. Herishanu, A. Braester, D. Azoulay, 2018, Experimental hematology.